Fasting insulin

There are 401 papers on fasting insulin in aging research: 129 trials and 166 observational studies in people, 22 in animals, 79 reviews. The newest story, Nov 18, 2026: “Low-intensity exercise improved fitness in women 85 and older”.

Biomarker

401 papers study it156 more mention it89 findings

52 new papers in 30 daysSee all 557 papers on fasting insulin

At a glance

Higher fasting insulin is linked with mortality, progression of diastolic dysfunction and mild cognitive impairment in human cohorts. Cognitive associations differ: in men with insulin below 22.2 mIU/L, higher levels are linked with lower dementia risk. Caloric restriction lowers fasting insulin in human trials; a trial also reports a reduction with a plant-forward diet.

89 findings in 79 papers from 1989 to 2026, 18 of them since April 2026

“individuals with higher baseline SPARC-1H levels were associated with fewer improvements in fasting insulin (β ± SE: 1.54 ± 0.43; P = 0.002)”
Predictive value of 1-hour postprandial SPARC levels on metabolic outcomes from Mediterranean diet adherence: results from a randomized controlled feeding studyLife metabolism2025doi:10.1093/lifemeta/loaf039
  • Human trial129
  • Humans166
  • Animals22
  • In silico2

Interventions

32

Caloric restriction

downin humans3downin rhesus monkeys1

4 studies
  1. Caloric restriction decreases fasting insulin in humans (overweight or obesity).

    “CR significantly improved fasting insulin (p < 0.001), HOMA-IR (p ≤ 0.001), and triglycerides (p = 0.009)”

    Human trialoverweight or obesity1,300 kcal/day12 weeksfemalesn = 26

    Changes in Total and Regional Body Composition Are Not the Primary Predictors of Metabolic Improvements Following Caloric Restriction in Females with Overweight or Obesity

    Frontiers in nutrition

  2. Caloric restriction decreases fasting insulin in humans (both diets compared, comparable reduction between arms) (-32% (L-RISK), -28% (H-RISK)).

    “Both diets resulted in comparable reduction of fasting concentrations of insulin (H-RISK -28% vs. L-RISK -32%, both p < 0.01)”

    Human trialboth diets compared, comparable reduction between arms8 weeks

    An 8-week diet high in cereal fiber and coffee but free of red meat does not improve beta-cell function in patients with type 2 diabetes mellitus: a randomized controlled trial

    Nutrition & metabolism

  3. Caloric restriction decreases fasting insulin in humans (P<.01).

    “fasting insulin levels were significantly reduced from baseline in the intervention groups (all P<.01)”

    Human trial6 monthsn = 48

    Effect of 6-month calorie restriction on biomarkers of longevity, metabolic adaptation, and oxidative stress in overweight individuals: a randomized controlled trial

    JAMA

  4. Caloric restriction decreases fasting insulin in rhesus monkeys.

    “Fasting and peak insulin were significantly reduced as were the acute and second-phase insulin responses.”

    Animalsmalesn = 13

    Short-term calorie restriction improves disease-related markers in older male rhesus monkeys (Macaca mulatta)

    Mechanisms of ageing and development

More on Caloric restriction

High-intensity interval training

downin humans1no changein humans1

2 studies
  1. High-intensity interval training showed no clear effect on fasting insulin in humans (compared with fish oil).

    “but not on fast insulin level to newly diagnosed non-obese type 2 diabetes”

    Human trialcompared with fish oil3 monthsn = 173

    Effect of fish oil supplementation combined with high-intensity interval training in newly diagnosed non-obese type 2 diabetes: a randomized controlled trial

    Journal of clinical biochemistry and nutrition

  2. High-intensity interval training decreases fasting insulin in humans (overweight/obesity; compared with usual care) (MD = -2.24 μU/mL versus usual care).

    “with HIIT demonstrating the greatest effects (FINS: MD = -2.24 μU/mL; HOMA-IR: MD = -0.67).”

    Reviewoverweight/obesity; compared with usual care

    Exercise and Insulin-Resistance Biomarkers in Adults With Overweight/Obesity: A Network Meta-Analysis of Randomised Controlled Trials

    Diabetes, obesity & metabolism

More on High-intensity interval training

Intermittent fasting

downin humans2

2 studies
  1. Intermittent fasting decreases fasting insulin in humans (young adults).

    “Young adults exhibited significant reductions in fasting insulin and HOMA-IR”

    Human trialyoung adults

    Age-Specific Analysis of the Effects of Intermittent Fasting on Body Composition and Cardiometabolic Markers in Healthy Adults and Individuals with Overweight or Obesity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    Nutrients

  2. Intermittent fasting decreases fasting insulin in humans (compared to CCR) (-7.46 pmol/L, p = 0.02).

    “FBS improved insulin sensitivity, with significant reductions in fasting insulin (-7.46 pmol/L, p = 0.02)”

    Reviewcompared to CCRn = 623

    Is Fasting Superior to Continuous Caloric Restriction for Weight Loss and Metabolic Outcomes in Obese Adults? A Systematic Review and Meta-Analysis of Randomized Clinical Trials

    Nutrients

More on Intermittent fasting

Tirzepatide

downin humans2

2 studies
  1. Tirzepatide decreases fasting insulin in humans (vs dulaglutide 0.75 mg once weekly, 52 weeks) (ETD -22.6%, -29.8%, -31.0% for 5, 10, 15 mg).

    “Fasting insulin and C-peptide levels were significantly reduced from baseline at week 52 at all three tirzepatide doses compared with dulaglutide 0.75 mg”

    Human trialvs dulaglutide 0.75 mg once weekly, 52 weeks5, 10, 15 mg once weekly52 weeksn = 636

    Insulin Sensitivity and Beta-Cell Function Following Tirzepatide in Japanese Patients with Type 2 Diabetes: A SURPASS J-mono Analysis

    Diabetes therapy : research, treatment and education of diabetes and related disorders

  2. Tirzepatide decreases fasting insulin in humans (compared with GLP-1 receptor agonists).

    “All doses of tirzepatide caused greater percent reductions in fasting insulin, C-peptide, and glucagon than GLP-1RAs.”

    Reviewcompared with GLP-1 receptor agonistsall doses (5, 10 and 15 mg)

    Pancreatic Safety of Tirzepatide and Its Effects on Islet Cell Function: A Systematic Review and Meta-Analysis

    Obesity science & practice

More on Tirzepatide

Acarbose

downin humans1no changein humans1

2 studies
  1. Acarbose decreases fasting insulin in thalassaemic patients with hyperinsulinism; untreated group unchanged.

    “A decrease of fasting insulin levels, insulin peak and area under the curve (AUC) after OGTT, were observed in thalassaemic patients receiving acarbose therapy.”

    Human trialin thalassaemic patients with hyperinsulinism; untreated group unchangedn = 5

    Effects of acarbose in beta-thalassaemia major patients with normal glucose tolerance and hyperinsulinism

    Pediatric endocrinology reviews : PER

  2. Acarbose showed no clear effect on fasting insulin in humans (fasting state).

    “fasting serum insulin and plasma C-peptide levels were unchanged after acarbose therapy”

    Human trialfasting state100 mg t.i.d.3 monthsn = 9

    Impaired glucose homeostasis in young adult thalassemic patients: a pilot study with acarbose

    Journal of pediatric endocrinology & metabolism : JPEM

More on Acarbose

GLP-1 receptor agonists

downin humans1

1 study
  1. GLP-1 receptor agonists decrease fasting insulin in humans (PMOS).

    “GLP-1RAs produced consistent reductions in weight, androgens and fasting insulin”

    ReviewPMOSfemales

    Structured nutritional management of insulin resistance in women with PMOS (formerly PCOS) receiving GLP-1RA therapy

    Diabetes research and clinical practice

More on GLP-1 receptor agonists

Sprint interval training

downin humans1

1 study
  1. Sprint interval training decreases fasting insulin in humans (versus no-exercise control).

    “Outcome-specific analyses favored SIT for fasting insulin, homeostatic model assessment of insulin resistance (HOMA-IR), low-density lipoprotein cholesterol (LDL-C), and total cholesterol (TC) versus no-exercise control”

    Reviewversus no-exercise control

    Effects of sprint interval training on markers of metabolic health: A three-level meta-analysis of randomised controlled trials

    Journal of sports sciences

More on Sprint interval training

Retatrutide

downin humans1

1 study
  1. Retatrutide decreases fasting insulin in humans (type 2 diabetes; compared with dulaglutide).

    “All retatrutide doses produced large fasting insulin reductions relative to dulaglutide, ranking above all tirzepatide doses.”

    Reviewtype 2 diabetes; compared with dulaglutideall doses

    Systematic review and network meta-analysis of the safety and efficacy of the triple incretin receptor agonist, retatrutide compared to the dual incretin receptor agonist, tirzepatide, for treatment of type 2 diabetes mellitus

    Therapeutic advances in endocrinology and metabolism

More on Retatrutide

Hormone replacement therapy

downin humans1

1 study
  1. Hormone replacement therapy decreases fasting insulin in humans (women without type 2 diabetes) (MD -5.90 pmol/l, 95% CI -8.03 to -3.77).

    “small reductions in fasting insulin (11 studies: N=4262, mean difference [MD] -5.90 pmol/l [95% confidence interval (CI) -8.03, -3.77 pmol/l]”

    Reviewwomen without type 2 diabetesfemalesn = 4,262

    Menopause hormone therapy and type 2 diabetes risk and prognosis: systematic review and meta-analyses

    Diabetologia

More on Hormone replacement therapy

Combined aerobic and resistance training

downin humans1

1 study
  1. Combined aerobic and resistance training decreases fasting insulin in humans (compared with no exercise) (SMD -1.68, 95% CrI -3.45 to -0.30).

    “combined aerobic and resistance exercise for fasting insulin (SUCRA = 94.30%; SMD:-1.68; 95% CrI: -3.45, -0.30)”

    Reviewcompared with no exercise

    Ranking exercise interventions by their effectiveness in the management of polycystic ovary syndrome: a systematic review and network meta-analysis

    Reproductive biology and endocrinology : RB&E

More on Combined aerobic and resistance training

Dapagliflozin

downin humans1

1 study
  1. Dapagliflozin decreases fasting insulin in humans (newly diagnosed T2DM receiving intensive insulin pump therapy).

    “greater decreases observed in the insulin pump therapy alone group and the insulin pump therapy + dapagliflozin group than in the insulin pump therapy + metformin group”

    Human trialnewly diagnosed T2DM receiving intensive insulin pump therapy

    The Impact of Different Oral Antidiabetic Drugs on Insulin Pump Intensive Therapy in Type 2 Diabetes Patients: A Clinical Study

    Journal of diabetes research

More on Dapagliflozin

Plant-forward diet

downin humans1

1 study
  1. Plant-forward diet decreases fasting insulin in a plant-forward diet.

    “Fasting insulin concentrations decreased in both diet phases (both, P < 0.001), suggesting improved insulin sensitivity across both plant-forward diets irrespective of primary protein source.”

    Human trialin a plant-forward diet8 wkn = 57

    Effects of Minimally Processed Red Meat within a Plant-Forward Diet on Biomarkers of Physical and Cognitive Aging: A Randomized Controlled Crossover Feeding Trial

    Current developments in nutrition

More on Plant-forward diet

Low-carbohydrate diet

downin humans1

1 study
  1. Low-carbohydrate diet decreases fasting insulin in humans (prediabetes) (LC -7.8 vs HC -4.1 mU/L, p=0.045).

    “reductions in fasting insulin (LC -7.8[-10.6,-5], HC -4.1[-6.9,-1.2] mU/L, p=0.045)”

    Human trialprediabetes24 weeksn = 40

    A Low-Carbohydrate, Low—Saturated Fat Diet to Treat β-Cell Dysfunction and Insulin Resistance in Asian Indians with Prediabetes—A 24-Week Randomized Trial

    ADA Scientific Sessions 2025 abstract

More on Low-carbohydrate diet

Taurine

downin humans1

1 study
  1. Taurine decreases fasting insulin in humans (WMD -2.15 μU/mL, 95% CI -3.24 to -1.06).

    “fasting insulin (WMD = -2.15 μU/mL, 95% CI: -3.24 to -1.06, p = 0.0001, I2 = 9%)”

    Human triallong-term

    Effect of Long-Term Taurine Supplementation on the Lipid and Glycaemic Profile in Adults with Overweight or Obesity: A Systematic Review and Meta-Analysis

    Nutrients

More on Taurine

Acarbose plus myo-inositol

downin humans1

1 study
  1. Acarbose plus myo-inositol decreases fasting insulin in humans.

    “Increase in serum progesterone and reduction in FI, TGL, LDL were significant only in acarbose plus myo-inositol group”

    Human trial6 monthsfemalesn = 54

    Effectiveness of dual combination therapy of acarbose plus metformin and acarbose plus myo-inositol in ameliorating the metabolic and endocrinologic complications of polycystic ovary syndrome - A randomized controlled trial

    European journal of obstetrics, gynecology, and reproductive biology

More on Acarbose plus myo-inositol

All 32

Effects

4

Type 2 diabetes

mediatesin humans1

1 study
  1. Fasting insulin is linked with type 2 diabetes in the association of short sleep duration with type 2 diabetes (20.3% of the total effect mediated).

    “Baseline fasting insulin level (proxy for insulin resistance) mediated 20.3% of the total effect.”

    Humansin the association of short sleep duration with type 2 diabetes

    Insulin resistance mediates the association between sleep duration and type 2 diabetes: Urban-rural evidence from a Chinese cohort study

    Medicine

More on Type 2 diabetes

Coronary artery disease

mediatesin silico1

1 study
  1. Fasting insulin mediates coronary artery disease in silico (from shorter telomeres to CHD pathogenesis).

    “Overall, our findings support a role of insulin as a mediator on the causal pathway from shorter telomeres to CHD pathogenesis.”

    In silicofrom shorter telomeres to CHD pathogenesis

    Exploring the Causal Pathway From Telomere Length to Coronary Heart Disease: A Network Mendelian Randomization Study

    Circulation research

More on Coronary artery disease

Sex hormone-binding globulin

downin humans1

1 study
  1. Fasting insulin is linked with lower sex hormone-binding globulin in humans (beta from 0.00044 to 0.00039).

    “After adjusting for fasting insulin, the relationship between log (SHBG) and age square was attenuated (beta coefficient from 0.00044 to 0.00039)”

    Humansfemales

    Sex hormone binding globulin levels across the adult lifespan in women--the role of body mass index and fasting insulin

    Journal of endocrinological investigation

More on Sex hormone-binding globulin

Arterial stiffness

no changein humans1

1 study
  1. Fasting insulin was not clearly linked with arterial stiffness in normotensives and newly diagnosed hypertensives.

    “arterial stiffness is not correlated with the fasting insulin level in normotensives and newly diagnosed hypertensives”

    Humansin normotensives and newly diagnosed hypertensivesmales

    Pulse wave velocity as an index of arterial stiffness: a comparison between newly diagnosed (untreated) hypertensive and normotensive middle-aged Malay men and its relationship with fasting insulin

    Acta cardiologica

Upstream

1

Telomere length

downin humans2downin silico1

3 studies
  1. Telomere length is linked with lower fasting insulin in humans (bidirectional Mendelian randomization) (p = 2.67E-05).

    “fasting insulin (p = 2.67E-05)”

    Humansbidirectional Mendelian randomization

    Telomere Length Is a Driving Hallmark for Aging-Related Biochemical Hallmarks: Evidence From the Shared Genetic Effect and Causal Inference

    The journals of gerontology. Series A, Biological sciences and medical sciences

  2. Telomere length is linked with lower fasting insulin in humans (β -0.041, 95% CI -0.062 to -0.020).

    “lower FI (β[95% CI]:-0.041[-0.062,-0.020]; P<0.001)”

    Humans

    Telomere length, Metabolic Traits, and Myocardial Infarction: A Mediation Mendelian Randomization Analysis

    Research SquarePreprint

  3. Telomere length decreases fasting insulin in silico (-0.07 (95% confidence interval, -0.01 to -0.12; P=0.01)).

    “One-unit increase of genetically determined TL was associated with -0.07 (95% confidence interval, -0.01 to -0.12; P=0.01) lower log-transformed fasting insulin (pmol/L)”

    In silico

    Exploring the Causal Pathway From Telomere Length to Coronary Heart Disease: A Network Mendelian Randomization Study

    Circulation research

More on Telomere length

Associations

40

Postprandial SPARC

upin humans1

1 study
  1. Postprandial SPARC predicts fasting insulin in the Mediterranean diet group from baseline to 6 months.

    “baseline SPARC-1H levels were positively associated with the changes in HOMA-IR (P = 0.0005), HOMA-β (P = 0.047), fasting insulin (P = 0.002), and fasting glucose (P = 0.049) from baseline to 6 months, specifically in the MD group”

    Human trialin the Mediterranean diet group from baseline to 6 months6 monthsn = 81

    Predictive value of 1-hour postprandial SPARC levels on metabolic outcomes from Mediterranean diet adherence: results from a randomized controlled feeding study

    Life metabolism

  2. Postprandial SPARC predicts fasting insulin in Mediterranean diet group (β = 1.54 ± 0.43, P = 0.002).

    “individuals with higher baseline SPARC-1H levels were associated with fewer improvements in fasting insulin (β ± SE: 1.54 ± 0.43; P = 0.002)”

    Human trialin Mediterranean diet groupplasma6 months

    Predictive value of 1-hour postprandial SPARC levels on metabolic outcomes from Mediterranean diet adherence: results from a randomized controlled feeding study

    Life metabolism

More on Postprandial SPARC

Metabolic syndrome

upin humans1OR 5.04

1 study
  1. Fasting insulin predicts metabolic syndrome in humans (non-diabetic) (AUC 0.78).

    “Area under receiver operating characteristic curve (ROC) curve (AUC) was 0.78, and cut-off value 7.35 μU/mL for FI was obtained (sensitivity: 0.69; specificity: 0.77).”

    Humansnon-diabetic

    Association between high-fasting insulin levels and metabolic syndrome in non-diabetic middle-aged and elderly populations: a community-based study in Taiwan

    BMJ open

  2. Fasting insulin is linked with a higher risk of metabolic syndrome in humans (non-diabetic, adjusted for confounders) (OR 5.04 (95% CI 2.15 to 11.81)).

    “OR (95% CI) of MetS was 5.04 (2.15 to 11.81) for high insulin groups compared with the low insulin group after adjusting confounders (P<0.001).”

    Humansnon-diabetic, adjusted for confounders

    Association between high-fasting insulin levels and metabolic syndrome in non-diabetic middle-aged and elderly populations: a community-based study in Taiwan

    BMJ open

More on Metabolic syndrome

LDL cholesterol

downin humans1

1 study
  1. Fasting insulin predicts LDL cholesterol in humans (R2 = 0.14, p = 0.002).

    “fasting insulin was the best predictor of LDL-C (R2 = 0.14; p = 0.002) irrespective of age, gender, BMI, waist circumference and TG”

    Humansn = 100

    Low density lipoprotein cholesterol, lipoprotein(a), and apo(a) isoforms in the elderly: relationship to fasting insulin. Associazione Medica Sabin

    Nutrition, metabolism, and cardiovascular diseases : NMCD

  2. Fasting insulin is associated with LDL cholesterol in humans (r = -0.28, p < 0.01).

    “a negative relation was found with TC and LDL-C (r = -0.29 and r = -0.28 respectively; p < 0.01)”

    Humansn = 100

    Low density lipoprotein cholesterol, lipoprotein(a), and apo(a) isoforms in the elderly: relationship to fasting insulin. Associazione Medica Sabin

    Nutrition, metabolism, and cardiovascular diseases : NMCD

More on LDL cholesterol

Metformin

downin humans1

1 study
  1. Metformin is associated with fasting insulin in humans.

    “During metformin treatment, reductions in fasting insulin and AKT–mTOR signaling were accompanied by improvements in Treg phenotype and suppressive function”

    Human trialSingle-arm intervention in obese hyperinsulinemic patients with relapsing-remitting multiple sclerosis24 weeksn = 28

    Hyperinsulinemia contributes to regulatory T-cell dysfunction and disease activity in multiple sclerosis

    Journal of neuroimmunology

More on Metformin

Fat mass

downin humans1

1 study
  1. Fat mass is associated with fasting insulin in humans (change from baseline to 24 weeks of tirzepatide) (r = 0.498).

    “the reduction in FM was significantly associated with the reduction in both insulin (r = 0.498, p < 0.05)”

    Humanschange from baseline to 24 weeks of tirzepatide24 weeks

    Real-world effectiveness of 6-month tirzepatide therapy on body weight and composition in adults with overweight and obesity

    Journal of diabetes and its complications

More on Fat mass

Chronic kidney disease

upin humans1

1 study
  1. Fasting insulin is associated with chronic kidney disease in humans (sustained hyperinsulinemia).

    “In the kidney, it enhances sodium and glucose reabsorption, increases intraglomerular pressure, and promotes podocyte dysfunction, potentially accelerating CKD progression.”

    Reviewsustained hyperinsulinemia

    Beyond Compensation: Hyperinsulinemia as an Early Driver of Cardiovascular-Kidney-Metabolic Syndrome

    Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia

More on Chronic kidney disease

Heart failure

upin humans1

1 study
  1. Fasting insulin is associated with heart failure in humans (sustained hyperinsulinemia).

    “Sustained hyperinsulinemia is associated with myocardial hypertrophy and fibrosis through selective preservation of mitogenic signalling, contributing to heart failure phenotypes.”

    Reviewsustained hyperinsulinemia

    Beyond Compensation: Hyperinsulinemia as an Early Driver of Cardiovascular-Kidney-Metabolic Syndrome

    Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia

More on Heart failure

Cardiovascular disease

upin humans1RR 1.46

1 study
  1. Fasting insulin raises the risk of cardiovascular disease in humans (elevated fasting insulin levels in meta-analytic estimates) (RR 1.46 (95% CI 1.16-1.84)).

    “meta-analytic estimates reporting a pooled relative risk of 1.46 (95% CI 1.16-1.84) for incident cardiovascular events”

    Reviewelevated fasting insulin levels in meta-analytic estimates

    Beyond Compensation: Hyperinsulinemia as an Early Driver of Cardiovascular-Kidney-Metabolic Syndrome

    Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia

More on Cardiovascular disease

Dietary fiber

downin humans1

1 study
  1. Dietary fiber is associated with fasting insulin in humans (unadjusted analysis) (r = -0.099).

    “Whole-food fiber intake was inversely associated with fasting insulin (r = -0.099)”

    Humansunadjusted analysiswhole-foodn = 820

    Dietary Fiber Intake, Food Sources, and Their Associations with Metabolic Parameters in Adults

    Nutrients

More on Dietary fiber

Prudent dietary pattern

downin humans1

1 study
  1. Prudent dietary pattern is associated with fasting insulin in humans (β = -0.05, p = 0.0021).

    “fasting insulin (β = -0.05, p = 0.0021)”

    Humans

    Association Between Prudent Dietary Pattern and Cardiometabolic Indicators in a Healthy Qatari Population: Evidence from the Qatar Biobank (QBB)

    Nutrients

More on Prudent dietary pattern

Spinal cord injury

upin humans1

1 study
  1. Spinal cord injury is associated with fasting insulin in humans (compared with non-SCI population, at baseline).

    “Baseline fasting insulin (p = 0.003) and lactate (p = 0.033) levels were higher in people with SCI”

    Human trialcompared with non-SCI population, at baselinen = 18

    Acute Low Force Electrically Induced Exercise Modulates Post Prandial Glycemic Markers in People with Spinal Cord Injury

    Journal of functional morphology and kinesiology

More on Spinal cord injury

PLIS score

upin humans1

1 study
  1. PLIS score is associated with fasting insulin in humans.

    “Performance of the PLIS score in tracking health gain was illustrated by association of the sex-specific PLIS scores with several classical metabolic health markers, such as BMI, trunk fat%, fasting HDL cholesterol, and fasting insulin”

    Human trial13-week

    PLIS: A metabolomic response monitor to a lifestyle intervention study in older adults

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology

More on PLIS score

AR

upin humans1

1 study
  1. AR is associated with fasting insulin in humans during testosterone replacement therapy.

    “AR CAG was independently positively associated with change in fasting insulin, triglycerides and diastolic blood pressure during TRT”

    Human trialduring testosterone replacement therapymalesn = 73

    The role of androgen receptor CAG repeat polymorphism and other factors which affect the clinical response to testosterone replacement in metabolic syndrome and type 2 diabetes: TIMES2 sub-study

    European journal of endocrinology

More on AR

All 40

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Reviews describe lower fasting insulin with interval training in humans and menopause hormone therapy in women without type 2 diabetes. Reviews also link elevated fasting insulin to cardiovascular disease risk and sustained hyperinsulinemia to chronic kidney disease and heart failure.

  2. Summary written from the findings.

Latest

Dec 2025: 14Jan 2026: 33Feb 2026: 28Mar 2026: 22Apr 2026: 5May 2026: 5Jun 2026: 18Jul 2026: 10Aug 2026: 15Sep 2026: 20Oct 2026: 31Nov 2026: 20221 papers in 12 months
European Review of Aging and Physical Activity

Low-intensity exercise improved fitness in women 85 and older

Handgrip strength was an estimated 3.71 kilograms higher with resistance training than in controls after 24 weeks; both exercise programs improved other fitness tests.Handgrip strength was an estimated 3.71 kilograms higher with resistance training than in controls after 24 weeks; both exercise programs improved other fitness tests.

Randomized trial · 90 peopleResistance training
EClinicalMedicine

Childhood metabolic patterns linked to diabetes and heart disease

Two subgroups had diabetes rates at least 13.24 times and heart disease rates at least 2.54 times those of the lowest-risk subgroup.Two subgroups had diabetes rates at least 13.24 times and heart disease rates at least 2.54 times those of the lowest-risk subgroup.

Cohort · 13,795 peopleType 2 diabetes

See all 557 papers on fasting insulin